
Afzeta 20mg Tablet
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Afatinib dimaleate (20mg)
Overview Afzeta 20mg Tablet
Azecta 20mg tablets are indicated for treating non-small cell lung cancer in adults with specific epidermal growth factor receptor (EGFR) gene mutations. Optimal absorption requires administration on an empty stomach, consistently at the same time daily. Dosage and frequency are determined by your physician, based on your individual needs and may vary over time; adhere strictly to their prescribed regimen. Incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include nausea, diarrhea (which can be severe; manage it as directed), rash, and dry skin. Regular blood monitoring may be necessary. Photosensitivity is possible; use sunscreen and protective clothing when exposed to sunlight. Report eye pain, redness, or dryness to your doctor. Prior to initiating treatment, disclose any respiratory, hepatic, or renal conditions, or concurrent use of anti-infective medications. Significant drug interactions are possible; inform your healthcare provider of all medications. This medication is contraindicated in pregnancy and lactation; reliable contraception is essential for female patients during treatment.
Uses of Afzeta 20mg Tablet
Lung cancer (excluding small cell type)
Major Benefits of Afzeta 20mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Afzeta 20mg Tablets should be taken on an empty stomach.
Common Side effects of Afzeta 20mg Tablet:
- Diarrhea
- Rash
- Dry skin
- Nausea
- Vomiting
- Loss of appetite
- Itching
- Stomatitis (Inflammation of the mouth)
- Nail disorder
How to use Afzeta 20mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 20mg Afzeta tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Afzeta 20mg Tablet works:
Afzeta 20mg tablets are an anti-neoplastic agent. Their mechanism of action involves targeted inhibition of EGFR, HER2, and HER4 enzyme receptors, crucial for cancer cell proliferation. This blockage disrupts intracellular signaling cascades, thereby hindering or reducing cancer progression.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Afzeta 20mg Tablet and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
The use of Afzeta 20mg Tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Afzeta 20mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Afzeta 20mg Tablet on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Afzeta 20mg tablets in individuals with kidney disease is likely safe. Preliminary findings indicate dose modification may not be necessary. However, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Afzeta 20mg tablets in patients with liver disease appears to pose minimal risk. Available evidence indicates that dosage modification may not be necessary. However, physician consultation is recommended.
What if you forget to take Afzeta 20mg Tablet :
Omit any missed Afzeta 20mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Afzeta 20mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline-Butenamide Hybrid |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | TKIs (Tyrosine Kinase Inhibitors) |
